TellBio
Pre-clinicalTellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17M
About
TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively.
Diagnostics
Funding History
2Total raised:$17M
Series A$12MApr 15, 2022
Seed$5MJan 15, 2020